In vivo humoral immune responses to isolated pneumococcal polysaccharides are dependent on the presence of associated TLR ligands

Journal of Immunology

Volumn 175, Issue 5, 2005, Pages 3084-3091

  Sen, Goutam ^a   Khan, Abdul Q ^a   Chen, Quanyi ^a   Snapper, Clifford M ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C POLYSACCHARIDE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 6; LIGAND; PHENOL; PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOCOCCUS POLYSACCHARIDE 3; PNEUMOCOCCUS VACCINE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG RESPONSE; HUMORAL IMMUNITY; IMMUNIZATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; SIGNAL TRANSDUCTION; STREPTOCOCCUS INFECTION;

EID: 23844555801     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.5.3084     Document Type: Article

References (36)

1. Peçanha, L. M. T., C. M. Snapper, F. D. Finkelman, and J. J. Mond. 1991. Dextran-conjugated anti-Ig antibodies as a model for T cell-independent type 2 antigen-mediated stimulation of Ig secretion in vitro. I. Lymphokine dependence. J. Immunol. 146: 833-839.
2. Snapper, C. M., and J. J. Mond. 1996. A model for induction of T cell-independent humoral immunity in response to polysaccharide antigens. J. Immunol. 157: 2229-2233.
3. Simpson, S. Q., R. Singh, and D. E. Bice. 1994. Heat-killed pneumococci and pneumococcal capsular polysaccharides stimulate tumor necrosis factor-α production by murine macrophages. Am. J. Respir. Cell Mol. Biol. 10: 284-289.
4. Soell, M., M. Diab, G. Haan-Archipoff, A. Beretz, C. Herbelin, B. Poutrel, and J.-P. Klein. 1995. Capsular polysaccharide types 5 and 8 of Staphylococcus aureus bind specifically to human epithelial (KB) cells, endothelial cells, and monocytes and induce release of cytokines. Infect. Immun. 63: 1380-1386.
5. Leiva, L. E., B. Butler, J. Hempe, A. P. Ortigas, and R. U. Sorensen. 2001. Up-regulation of CD40 ligand and induction of a Th2 response in children immunized with pneumococcal polysaccharide vaccines. Clin. Diag. Lab. Immunol. 8: 233-240.
6. Jagger, M. P., Z. Huo, and P. G. Riches. 2002. Inflammatory cytokine (interleukin 6 and tumor necrosis factor a) release in a human whole blood system in response to Streptococcus pneumoniae serotype 14 and its capsular polysaccharide. Clin. Exp. Immunol. 130: 467-474.
7. Yamamoto, M., K. Takeda, and S. Akira. 2004. TIR domain-containing adaptors define the specificity of TLR signaling. Mol. Immunol. 40: 861-868.
8. Schnare, M., G. M. Barton, A. C. Holt, K. Takeda, S. Akira, and R. Medzhitov. 2001. Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2: 947-950.
9. Echchannaoui, H., K. Frei, C. Schnell, S. I. Leib, W. Zimmerli, and R. Landmann. 2002. Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation. J. Infect. Dis. 186: 798-806.
10. Koedel, U., B. Angele, T. Rupprecht, H. Wagner, A. Roggenkamp, H.-W. Pfister. and C. J. Kirschning. 2003. Toll-like receptor 2 participates in mediation of immune response to experimental pneumococcal meningitis. J. Immunol. 170: 438-444.
11. Schwandner, R., R. Dziarski, H. Wesche, M. Rothe, and C. J. Kirschning. 1999. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J. Biol. Chem. 274: 17406-17409.
12. Malley, R., P. Henneke, S. C. Morse, M. J. Cieslewicz, M. Lipsitch, C. M. Thompson, E. Kurt-Jones. J. C. Paton, M. R. Wessels, and D. T. Golenbock. 2003. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc. Natl. Acad. Sci. USA 100: 1966-1971.
13. Khan, A. Q., Q. Chen, Z.-Q. Wu, J. C. Paton, and C. M. Snapper. 2005. Innate and type 1 humoral immunity to Streptococcus pneumoniae are both mediated by MyD88, but differ in their relative dependence on Toll-like receptor 2. Infect. Immun. 73: 298-307.
14. Smit, P., D. Oberholzer, S. Hayden-Smith, H. J. Koornhof, and M. R. Hilleman. 1977. Protective efficacy of pneumococcal polysaccharide vaccines. J. Am. Med. Assoc. 238: 2613-2616.
15. Black, S., H. Shinefield, B. Fireman, E. Lewis, P. Ray, J. R. Hansen, L. Elvin, K. M. Ensor, J. Hackell, G. Siber, et al. 2000. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children: Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr. Infect. Dis. J. 19: 187-195.
16. Takeuchi, O., K. Hoshino, T. Kawai, H. Sanjo, H. Takada, T. Ogawa, K. Takeda, and S. Akira. 1999. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 11: 443-451.
17. Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi, and S. Akira. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1 and IL-18-mediated function. Immunity 9: 143-150.
18. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. V. Huffel, S. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088.
19. Wu, Z.-Q., Q. Vos, Y. Shen, A. Lees, S. R. Wilson, D. E. Briles, W. C. Gause, J. J. Mond, and C. M. Snapper. 1999. In vivo polysaccharide-specific IgG isotype responses to intact Streptococcus pneumoniae are T cell dependent and require CD40- and B7-ligand interactions. J. Immunol. 163: 659-667.
20. Hirschfeld, M., Y. Ma, J. H. Weis, S. N. Vogel, and J. J. Weis. 2000. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine Toll-like receptor 2. J. Immunol. 165: 618-622.
21. Wu, Z.-Q., A. Q. Khan, Y. Shen, K. M. Wolcott, W. Dawicki, T. H. Watts, R. S. Mittler, and C. M. Snapper. 2003. 4-1BB (CD137) differentially regulates murine in vivo protein- and polysaccharide-specific immunoglobulin isotype responses to Streptococcus pneumoniae. Infect. Immun. 71: 196-204.
22. Baker, P. J. 1992. T cell regulation of the antibody response to bacterial polysaccharide antigens: an examination of some characteristics and their implications. J. Infect. Dis. 165(Suppl. 1): S44-S48.
23. Mond, J. J., A. Lees, and C. M. Snapper. 1995. T cell-independent antigens type 2. Annu. Rev. Immunol. 13: 655-692.
24. Jeurissen, A., M. Wuyts, A. Kasran, S. Ramdien-Murli, L. Boon, J. L. Ceuppens, and X. Bossuyt. 2002. Essential role for CD40 ligand interactions in T lymphocyte-mediated modulation of the murine immune response to pneumococcal capsular polysaccharides. J. Immunol. 168: 2773-2781.
25. Wheeler, K., J. D. Pound, J. Gordon, and R. Jefferis. 1993. Engagement of CD40 lowers the threshold for activation of resting B cells via antigen receptor. Eur. J. Immunol. 23: 1165-1168.
26. Snapper, C. M., M. R. Kehry, B. E. Castle, and J. J. Mond. 1995. Multivalent, but not divalent, antigen receptor cross-linkers synergize with CD40 ligand for induction of Ig synthesis and class switching in normal murine B cells. J. Immunol. 154: 1177-1187.
27. Alonsode Velasco, E., A. F. M. Verheul, J. Verhoef, and H. Snippe. 1995. Streptococcus pneumoiniae: virulence factors, pathogenesis, and vaccines. Microbiol. Rev. 59: 591-603.
28. Dempsey, P. W., M. E. d. Allison, S. Akkaraju, C. C. Goodnow, and D, T. Fearon. 1996. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271; 348-350.
29. Test, S. T., J. Mitsuyoshi, C. C. Connolly, and A. H. Lucas. 2001. Increased immunogenicity and induction of class switching by conjugation of complement C3d to pneumocoecal serotype 14 capsulai polysaccharide. Infect. Immun. 69: 3031-3040.
30. Snapper, C. M., H. Yamaguchi, M. A. Moorman, and J. J. Mond. 1994. An in vitro model for T cell-independent induction of humoral immunity: a requirement for NK cells. J. Immunol. 152: 4884-4892.
31. Lee, H. K., J. Lee, and P. S. Tobias. 2002. Two lipoproteins extracted from Escherichia coli K-12 LCD25 lipopolysaccharide are the major components responsible for Toll-like receptor 2-mediated signaling. J. Immunol. 168: 4012-4017.
32. Hashimoto, M., Y. Asai, and T. Ogawa. 2004. Separation and-structural analysis of lipoprotein in a lipopolysaccharide preparation from Porphyromonas gingivalis. Int. Immunol. 16: 1431-1437.
33. Vanlandschoot, P., F. V. Houtte, P. Ulrichts, J. Tavernier, and G. Leroux-Roels. 2005. Immunostimulatory potential of hepatitis B nucieocapsid preparations: lipopolysaccharide contamination should not be overlooked. J. Gen. Virol. 86: 323-331.
34. Snapper, C. M., T. M. McIntyre, R. Mandler, L. M. T. Pecanha, F. D. Finkelman, A. Lees, and J. J. Mond. 1992. Induction of IgG3 secretion by interferon γ: a model for T cell-independent class switching in response to T cell-independent type 2 antigens. J. Exp. Med. 175: 1367-1371.
35. Snapper, C. M., and W. E. Paul. 1987. Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236: 944-947.
36. Latz, E., J. Franko, D. T. Golenbock, and J. R. Schreiber. 2004. Haemophilus influenza? type b-outer membrane protein complex glycoconjugate vaccine induces cytokine production by engaging human TolJ-Jtke receptor 2 (TLR2) and requires the presence of TLR2 for optimal immunogenicity. J. Immunol. 172: 2431-2438.